Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Study Group: Pricing Experts on Clinical Lab Testing in the U.S.

Council Members in this Study Group: 57

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

John Waugh, Director of System Laboratory Operations, HENRY FORD HEALTH SYSTEMJohn Waugh

Director of System Laboratory Operations
HENRY FORD HEALTH SYSTEM
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

John Waugh is the Director of System Laboratory Operations at Henry Ford Health System, one of the top ten US laboratories in size. In this research and academic medical center in Detroit, Mr. Waugh has expertise in new and emerging clinical and molecular diagnostic systems, including products andservices...

1 recent event(s)
Stan Schofield, MS, MHA,MT(ASCP), Managing Principal, The Compass Group, ScarboroughStan Schofield, MS, MHA,MT(ASCP)

Managing Principal
The Compass Group, Scarborough
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Stan Schofield, MS, MHA, MT (ASCP), is President of NorDx, a regional laboratory corporation which is part of the Maine Health System. He also serves as a Vice President and senior member of the health system executive management team. Mr. Schofield is the Managing Principal of the Compass Group, a...

Robert Boorstein, MD, PhD

Associate Professor, Pathology
NEW YORK UNIVERSITY (INC)
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Robert Boorstein, MD, PhD, is an Associate Professor in the Department of Pathology at New York University School of Medicine, where he directs clinical pathology training. Previously, Dr. Boorstein was the Director of Pathology at Bellevue Hospital and the Medical Director for Pathology and Laboratory...

17 recent news post(s)
Ken Powell, President, Genesis Business Development, LLCKen Powell

President
Genesis Business Development, LLC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Ken Powell is the President of Genesis Business Development, a healthcare consultancy. Mr. Powell has experience in the identification, acquisition, and commercialization of intellectual property, new businesses, and products in the clinical diagnostics and medical device market segments. He has knowledge...

196 recent news post(s)
Carrie Harris-Muller, MBA, MHA

Chief Administrative Officer
KAISER FOUNDATION HOSPITALS INC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Carrie Harris-Muller is the Chief Administrative Officer of Kaiser Permanente in the Mid-Atlantic States. Previously, Ms. Harris-Muller served as the Regional Vice President of HealthPlan Administration and Contracting. She has held several executive leadership positions in healthcare, including Cigna...

John Cochran, MD

Founder and Senior Pathologist
Chestatee Pathology Associates, PC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

John Cochran, MD, is the Founder and the Chief Executive Officer of Chestatee Pathology Associates in Atlanta, GA. He is also the Medical Director of two Atlanta-area hospital laboratories and founded the first independent podiatric pathology laboratory in the U.S. Dr. Cochran has consulted on thefollowing...

Joseph Schappert, MD

Medical Director
PROVIDENCE HEALTH CARE
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Joseph Schappert, MD, is the Chief Medical Officer at Pathology Associates Medical Laboratories (PAML) and the Medical Director for Providence Health Care System. He was previously the Global Medical Director at ICON Central Laboratories, where he was involved in innovative and state-of-art information...

4 recent news post(s)

GLG NewsSM Analyses by this Study Group's Leading Experts (?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Will Quest Acquire Vermillion?

November 20, 2009

Ken Powell, President, Genesis Business Development, LLC

Why Quest Will Acquire Vermillion | www.genomeweb.com

Quest Diagnostics has had a known relationship with Vermillion.  Now that Vermillion has received FDA approval for its OVA1 in vitro diagnostic multi-variant index assay (IVDMIA) and Quest has an exclusive three year marketing license and a 17% investment in the company plus additional loans, acquisition...

Roche Receives H1N1 FDA Emergency Use Authorization

November 16, 2009

Ken Powell, President, Genesis Business Development, LLC

Roche Gets FDA EUA for H1N1 Test Kit | www.genomeweb.com

Roche has received an Emergency Use Authorization from the FDA for its RealTime ready Influenza A/H1N1 Detection Set.  The new H1N1 assay is run on its MagNA Pure LC platform for nucleic acid isolation and its LightCycler 2.0 system for real-time PCR applications.  Roche, the worldwide clinical diagnostics...

Sequenom Sued by Shareholders

November 14, 2009

Ken Powell, President, Genesis Business Development, LLC

Sequenom Shareholders Sue Company, Officials over SEQureDx Data Mishandling | www.genomeweb.com

The Sequenom sage appears endless.  Following the "mishandling of data" involving the company's Down's syndrome test, termination of company executives, investigation by the NASDAQ , the SEC and the US Attorney for the Southern District of California, Xenomics lawsuit against Sequenom seeking up...

Epigenomics Reports Excellent 3Q Returns

November 12, 2009

Ken Powell, President, Genesis Business Development, LLC

Epigenomics Nearly Quadruples Sales in Q3 | www.genomeweb.com

Germany based Epigenomics posted stellar Q3 financial results and reduced net loss by 8%.  According to the company, the increase comes from existing collaborations, new partnerships, and license agreements

New Sample Prep Company

November 12, 2009

Ken Powell, President, Genesis Business Development, LLC

Life Technologies to Buy Biotrove, Which Will Form Mass Spec Sample Prep Company | www.biotrove.com

Following on Life Technologies' (NASDAQ: LIFE) acquisition of Biotrove, Biotrove announced in a separate release that it will form a subsidiary for a sample handing company for mass spectroscopy systems.  This could be the real opportunity for future growth.

View All GLG News by members of this Study Group

Members in this Study Group include these company types:

  • Laboratory, Independent
  • Consultancy, Healthcare-Focused
  • Academic Medical Center/Hospital or Clinic
  • Lab, Academic Medical Center
  • Lab, Non-Academic/Community Hospital
  • Managed Care Health Insurer, For-Profit
  • Academic Institution*
  • Integrated Healthcare Delivery Network (IDN)
  • Lab, Government/Public Hospital
  • Medical Device Manufacturer
  • Office Based Private Practice or Clinic
  • Other Health Insurer, Non-Profit

Members in this Study Group often have these job titles:

  • Director
  • President
  • Chief Executive Officer
  • Principal
  • Consultant
  • Research Scientist
  • Physician - Director
  • Medical Director
  • Professor
  • Operations Executive
  • Physician - Department Chair
  • Physician - Attending Physician

Related Study Groups

Study Group Name No. Members
Economic Experts on Managed Care 714
Pathologists (US) 792
Users of Triage BNP Test (US) 35
Users of Invader DNA Analyte Specific Reagents (US) 21
Users of Mass Spectrometers in the U.S. 92
Managed Care Experts 669
Users of APTIMA Combo 2 for Testing Chlamydia and Gonorrhea (US) 17

GLG Live Meetings with this Study Group's Leading Experts (?)

Upcoming Seminars

Leading Experts in Pricing Experts on Clinical Lab Testing in the U.S. Study Group have not participated in any upcoming seminars.

View All GLG Live Meetings in Healthcare

GLG Webcasts

Leading Experts in Pricing Experts on Clinical Lab Testing in the U.S. have not participated in any GLG webcasts.

View All GLG Webcasts in Healthcare